Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up of ABT-333 Resistance in HCV
NCT00726882Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dasabuvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Aug 2008; status: completed.
02
Drugs
dasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00726882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726882.